Polymer Factory publicerar årsredovisning för 2025
27 mars, 13:51
27 mars, 13:51
Polymer Factory publicerar årsredovisning för 2025
Årsredovisningen på svenska finns bifogad.
Den finns även tillgänglig att ladda ner på bolagets hemsida (www.polymerfactory.com).
Årsredovisningen kan beställas per post på adress Polymer Factory Sweden AB (publ), Teknikringen 48, 114 28 Stockholm eller per e-post (investor@polymerfactory.com).
Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.
For more information, please contact:
Mats Wallnér, CEO
Phone: +46 (0) 70 951 95 06
E-mail: mats.wallner@polymerfactory.com
27 mars, 13:51
Polymer Factory publicerar årsredovisning för 2025
Årsredovisningen på svenska finns bifogad.
Den finns även tillgänglig att ladda ner på bolagets hemsida (www.polymerfactory.com).
Årsredovisningen kan beställas per post på adress Polymer Factory Sweden AB (publ), Teknikringen 48, 114 28 Stockholm eller per e-post (investor@polymerfactory.com).
Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.
For more information, please contact:
Mats Wallnér, CEO
Phone: +46 (0) 70 951 95 06
E-mail: mats.wallner@polymerfactory.com
Rapporter
Analys

Rapporter
Analys

1 DAG %
Senast
OMX Stockholm 30
−0,58%
(12:21)
Saab
Idag, 10:58
Saabs VD: Försvaret är för splittrat
Stegra
Idag, 10:51
LKAB öppnar för leveranser till Stegra
OMX Stockholm 30
1 DAG %
Senast
3 110,30